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Abstract 1 
Purpose: Ischemic preconditioning enhances exercise performance. We tested the hypothesis 2 
that ischemic preconditioning would improve intermittent exercise in the form of a repeated 3 
sprint test during cycling ergometry. Methods: In a single-blind, crossover study, fourteen 4 
recreationally-active males (mean ± SD; age 22.9 ± 3.7 years, height 1.80 ± 0.07 m, mass 5 
77.3 ± 9.2 kg) performed twelve 6 s sprints following four 5 min periods of bilateral limb 6 
occlusion at 220 mmHg (ischemic preconditioning) or 20 mmHg (placebo). Results: 7 
Ischemic preconditioning resulted in a 2.4 ± 2.2, 2.6 ± 2.7 and 3.7 ± 2.4% substantial increase 8 
in peak power for sprints 1, 2 and 3 respectively, relative to placebo, with no further changes 9 
between trials observed for any other sprint. Similar findings were observed in the first three 10 
sprints for mean power output following ischemic preconditioning (2.8 ± 2.5, 2.6 ± 2.5 and 11 
3.4 ± 2.1%, for sprints 1, 2 and 3 respectively), relative to placebo. Fatigue index was not 12 
substantially different between trials. At rest tissue saturation index was not different between 13 
trials. During the ischemic preconditioning / placebo stimulus there was a -19.7 ± 3.6% 14 
decrease in tissue saturation index in the ischemic preconditioning trial, relative to placebo. 15 
During exercise there was a 5.4 ± 4.8% greater maintenance of tissue saturation index in the 16 
ischemic preconditioning trial, relative to placebo. There were no substantial differences 17 
between trials for blood lactate, electromyography (EMG) median frequency, oxygen uptake 18 
or rating of perceived exertion (RPE) at any time points. Conclusion:  Ischemic 19 
preconditioning improved peak and mean power output during the early stages of repeated 20 
sprint cycling and may be beneficial for sprint sports. 21 
Key Words: Ischemia, occlusion, power output, multiple sprint, fatigue 22 
 23 
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Introduction 24 
Ischemia-reperfusion injury underpins the damage caused by either disease and /or 25 
deliberately imposed interruption of blood supply to tissues. However, since 1986, brief and 26 
repeated bouts of ischemia / reperfusion, known as ischemic preconditioning, have been 27 
demonstrated to protect many organs, including the myocardium (32), liver (35) and skeletal 28 
muscle (21), from the damage caused by a subsequent prolonged ischemic event. In addition 29 
to the clinical use of ischemic preconditioning, this technique has also been applied 30 
immediately before exercise to improve performance. Across a range of various exercise 31 
modes, performance has been enhanced by 1-8% (3, 12, 13, 24, 25) which makes it 32 
potentially beneficial for athletic events where such small margins are the difference between 33 
winning or losing.  34 
Research to date has primarily focussed on events of an endurance nature and has identified 35 
improvements in peak oxygen uptake (V̇O2max; 13), power output at V̇O2max (12), running 36 
time trial performance (3), 1000 m rowing performance (25) and time to task failure (7) 37 
following ischemic preconditioning.  Relatively little research has focused on performance 38 
during shorter durations and the findings are conflicting. For example, an improvement in 39 
100 m swimming performance was observed in elite national level swimmers (24) but no 40 
effect of ischemic preconditioning was demonstrated on single 30 m running sprint 41 
performance (19) or cycling exercise at 130% V̇O2max (12).   42 
Repeated sprint exercise provides a model to investigate transitions from high to low 43 
metabolic work, a common feature of many team sports. The major energy demands of 44 
repeated sprint exercise are derived from phosphocreatine (PCr) and anaerobic glycolysis 45 
(18), and recent work suggests a strong relationship between PCr resynthesis and recovery of 46 
repeated sprint performance (31). Alternatively, there is an increased reliance on aerobic 47 
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energy production during the latter stages of repeated intense exercise as evidenced by a 48 
larger reduction in anaerobic energy production than performance (18, 30) and increased 49 
muscle oxygen uptake (6). Furthermore, reducing (5) or enhancing (4) oxygen availability 50 
during repeated exercise impaired or enhanced performance, respectively, which suggests 51 
that the aerobic system plays an important role, possibly through faster PCr resynthesis.  52 
Ischemic preconditioning may improve aerobic metabolism as evidenced by increased 53 
V̇O2max (13), accelerated V̇O2 kinetics (34) and improved oxygenation of skeletal muscle (38) 54 
and it may therefore reduce the performance related decline in power output associated with 55 
repeated sprint exercise. Secondly, in ischemic reperfusion injury models, ischemic 56 
preconditioning enhances PCr resynthesis following ischemia (1, 29) and thus may enhance 57 
the ability to recover between sprints. Therefore, the aim of this study was to investigate the 58 
effect of ischemic preconditioning on repeated sprint cycling performance. Given the 59 
apparent ability of ischemic preconditioning to improve aerobic metabolism and promote PCr 60 
resynthesis it was hypothesized that it would improve repeated sprint cycling performance by 61 
reducing the rate of fatigue.  62 
 63 
METHODS 64 
Participants 65 
 In a randomized, single blind, crossover study, fourteen healthy males (mean ± 66 
standard deviation (SD); age 22.9 ± 3.7 years, height 1.80 ± 0.07 m, mass 77.3 ± 9.2 kg) 67 
recreationally active in repeated sprint sports such as field hockey, soccer and rugby, 68 
volunteered to participate. Participants were naïve to the effect of ischemic preconditioning 69 
on exercise performance and were not informed about the rationale of the study. They were 70 
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fully informed of all procedures and associated risks before completing a training history 71 
questionnaire and providing written, informed consent. Participants reported they had 72 
actively been involved in sport for an average of 12 years, with time spent training each week 73 
reported as 6.7 ± 2.3 hours. Approval for the study's procedures was granted by St Mary's 74 
University Ethics Committee which conformed to the Declaration of Helsinki. 75 
Experimental Overview 76 
 All participants reported to the laboratory for four exercise trials. In the initial trial, 77 
data were obtained on individual anthropometric characteristics such as body mass, height 78 
and four skinfolds (subscapular, biceps brachii, triceps brachii, and iliac crest). During this 79 
trial participants were familiarised with the repeated sprint cycling protocol, consisting of 80 
twelve 6 s cycle sprints with 30 s of passive recovery between each sprint. Trial 2 was a 81 
repeat of the first, to further familiarise the participants with the exercise protocol. Trials 3 82 
and 4 were the experimental trials which consisted of either ischemic preconditioning or 83 
placebo treatment prior to the exercise protocol. The experimental trials were performed in a 84 
counterbalanced manner, separated by 5-7 days to ensure no possible carryover of acute 85 
ischemic preconditioning (28). During both trials respiratory gas exchange, 86 
electromyography (EMG) of the vastus lateralis (VL) and near-infrared spectroscopy (NIRS) 87 
of the VL were recorded. Participants indicated their rating of perceived exertion (RPE, 6 – 88 
20; Borg’s scale) and blood was taken from the earlobe at rest and following sprints 4, 8 and 89 
12 before being subsequently analyzed for lactate. Participants performed all of their trials at 90 
the same time of day (±1 h) and laboratory conditions were controlled at approximately 20°C 91 
and 38% relative humidity during all trials. Participants were instructed to maintain their 92 
normal diet, to refrain from any form of intense physical activity and caffeine for the 24 h 93 
period prior to testing, and not to eat for 3 h before each trial.  94 
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Experimental Measures 95 
Ischemic Preconditioning 96 
 In trials 3 and 4 exercise was preceded by ischemic preconditioning or placebo, 97 
performed in a supine position using bilateral occlusion (3, 13). In the ischemic 98 
preconditioning trial automatic occlusion cuffs (14.5 cm width - Delfi Medical Innovations, 99 
Vancouver, Canada) were positioned proximally around the thigh and inflated to 220 mmHg 100 
for 5 minutes followed by 5 minutes of reperfusion. This procedure was repeated four times 101 
(3). The placebo trial was identical to the ischemic preconditioning trial except that the cuffs 102 
were inflated to 20 mmHg. The time delay between the cuff removal and the beginning of the 103 
warm up for the exercise test was 30 minutes as ischemic preconditioning has been 104 
demonstrated to improve exercise performance within 45 minutes of the final cuff inflation 105 
(3).  106 
Repeated-sprint cycling 107 
 The exercise protocol consisted of twelve 6 s sprints with resistance set at a torque 108 
factor of 1.0 N·m·kg
-1
 on a cycle ergometer (Lode Excalibur Sport, Groningen, The 109 
Netherlands) with individual participant cycling position being established during visit 1 and 110 
then replicated on each subsequent visit. Participants performed a standardized warm-up, 111 
consisting of 3 minutes of cycling at 120 W, followed by two maximal 6 s sprints, with 1 112 
minute between efforts followed by 5 minutes of passive rest. Toe clips were used to secure 113 
the feet to the pedals and strong verbal encouragement was provided throughout each trial. 114 
Participants performed each sprint with the pedals in the same starting position and were 115 
instructed to sprint as fast as possible maintaining maximal effort until asked to stop. Each 116 
sprint was initiated by illuminating a series of 20 light emitting diodes (LEDs) which were 117 
synchronized with the EMG recording.  During the 30 s rest period after each sprint 118 
 The is a non-final version of an article published in final form in Medicine and Science in 
Sport and Exercise (2015) Aug;47(8):1652-8. doi: 10.1249/MSS.0000000000000576 
 
participants remained seated on the ergometer. Mean and peak power output were calculated 119 
for each condition. The percentage decrement score (Sdec) for all 12 sprints was calculated as 120 
the percent difference between total and ideal peak power output, where total power 121 
represents the sum of peak power values from all sprints (Sn where n = 1:12) and ideal power 122 
represents the number of sprints multiplied by the highest peak power (Sbest) achieved (20). 123 
    124 
𝑆𝑑𝑒𝑐(%) = [1 −
(𝑆1 + 𝑆2+. . . 𝑆12)
𝑆𝑏𝑒𝑠𝑡 × 12
] × 100 
Cardiorespiratory Measures 125 
 Respiratory gas exchange was measured during the entire exercise protocol through 126 
breath-by-breath analysis using an open spirometric system (Oxycon Pro, Jaeger, Hoechburg, 127 
Germany). The gas analyser was calibrated prior to each trial using oxygen and carbon 128 
dioxide gases of known concentrations (Cryoservice, Worcester, UK), and the turbine volume 129 
transducer was calibrated using a 3 L precision syringe (Hans Rudolph Inc, Shawnee, USA). 130 
During the trials participants breathed room air through a facemask (Hans Rudolph, Kansas 131 
City, MO, USA) that was secured in place by a head-cap assembly (Hans Rudolph, Kansas 132 
City, MO, USA). Respiratory gas exchange data were subsequently averaged on a 1 s basis 133 
and then averaged for the overall exercise protocol, so that the total time of analysis was 432 134 
s ((12 × (6 s sprint + the following 30 s recovery periods)). 135 
Muscle EMG 136 
 The EMG activity of the VL muscle of the right leg was recorded at 1000 Hz using a 137 
data acquisition system (Biopac MP150, Biopac Systems Inc. CA, USA). Before placement 138 
of the electrodes, the overlying skin was prepared. The hair was shaved and the skin 139 
thoroughly cleaned with alcohol to reduce skin electrode interference. Pre-gelled disposable 140 
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hypoallergenic 1 cm snap-electrodes (Performance Plus, Vermed, VT, USA) were fixed two-141 
thirds of the distance along a line from the anterior spina illaca superior to the lateral side of 142 
the patella (17). Electrode centres were placed 2.0 cm apart, parallel to the direction of 143 
muscle fibres, with a reference electrode located above a prepared site on the shaft of the 144 
tibia. The EMG electrode placement was marked on the skin by indelible pen to ensure 145 
similar placement of electrodes between experimental trials. EMG recording was initiated by 146 
a digital trigger coincident with the start of each 6 s sprint. The start of each sprint was 147 
identified from the square wave pulse provided by the synchronization trigger and the 148 
subsequent 6 s of data were used for the analysis of each individual sprint. The raw EMG 149 
data were band pass filtered to remove the signal outside of the 20 – 500 Hz range. To 150 
investigate the difference in VL EMG frequency between the two conditions, the filtered 151 
EMG data from each sprint were transformed in to the frequency domain using a fast Fourier 152 
transformation and the median frequency (MDF) of the resulting power spectrum density was 153 
calculated. The MDF values from each of the 12 sprints were then analysed using linear 154 
regression, and the gradient of this line was extracted as a representation of the change in 155 
frequency (fatigue) across the 12 sprints (33).  156 
 157 
NIRS Measurements 158 
 During experimental trials, muscle oxygenation of the left VL was continuously 159 
monitored using portable NIRS apparatus which is a wireless spatially resolved dual-160 
wavelength spectrometer (Portamon, Artinis Medical Systems, BV, The Netherlands). 161 
Changes in tissue saturation index (TSI, expressed as a %) were measured using two 162 
wavelengths (750 and 850 nm), using an arbitrary value for the differential pathlength of 3.83 163 
(10). During rest and prior to the preconditioning procedure a measure of TSI was taken. 164 
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During the preconditioning and placebo procedures, TSI was averaged over the duration of 165 
each 5 minute period of ischemic preconditioning and the value used was for the portion of 166 
time the cuff was inflated only (4 × 5 minutes of pressure). During the repeated sprint cycling 167 
protocol, TSI was calculated as an average across all the sprints and recovery time, in a 168 
similar manner to oxygen uptake data described above. The NIRS device was positioned on 169 
the left VL using the same procedures described above for the EMG placement (for the 170 
opposite leg). As with EMG placement an indelible pen was used to mark the placement of 171 
the device and to ensure similar placement between trials. The NIRS device was covered with 172 
a black light-absorbing cloth to prevent contamination from ambient light. During all tests the 173 
NIRS device was connected to a personal computer by Bluetooth for data acquisition (10 174 
Hz). Skinfold thickness was measured at the site where the NIRS probe was attached before 175 
each trial using Harpenden skinfold calipers (British Indicators Ltd, UK). For all participants, 176 
the calculated value of skin and subcutaneous tissue thickness was less than half of the 177 
distance between the source and the detector.  178 
Blood Lactate Measurement 179 
 The right ear lobe was cleaned using an alcohol swab and punctured using an 180 
automated lancet. At rest and immediately following sprints 4, 8 and 12, a blood sample was 181 
drawn using a 20 µl capillary tube (EKF Diagnostics, Barleben, Germany). The whole blood 182 
sample was hemolysed in a pre-filled micro test tube and analysed using a blood 183 
lactate/glucose analyser (Biosen C_Line, EKF Diagnostics, Barleben, Germany).  184 
Statistical Analysis 185 
 Data were analysed using a contemporary magnitude-based inferences approach (22) 186 
because small changes in performance can be meaningful in athletes. Data were log 187 
transformed to reduce non-uniformity of error except for RPE due to its interval nature. The 188 
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threshold value for the smallest meaningful change for mean and peak power output was set 189 
as 0.8% (2).  For all other data, the smallest worthwhile or important effect for each 190 
dependent variable was the smallest standardised (Cohen) change in the mean: 0.2 times the 191 
between-subject SD for baseline values of all participants (8). Qualitative descriptors were 192 
assigned to the quantitative percentile scores as follows: 25–75% possible; 75–95% likely; 193 
95–99% very likely; >99% almost certain (20). A substantial effect was set at > 75%. Effect 194 
size was calculated using threshold values for Cohen’s d statistics (0.2; small, 0.5; moderate 195 
and 0.8; large). Data are presented as mean ± SD or percent change from placebo (%∆ ± 90% 196 
confidence interval (± 90% CI)), percent likelihood that the difference between conditions 197 
was larger or smaller (% likelihood) and effect size). An effect was deemed unclear if its 198 
confidence limits overlapped the thresholds for both the smallest beneficial and the smallest 199 
harmful effect, that is, if the effect could be substantially positive and negative. 200 
 201 
RESULTS 202 
The maximal peak power (mean ± SD) obtained during the repeated sprint cycling test was 203 
1594 ± 208 and 1630 ± 192 W for placebo and ischemic preconditioning, respectively. 204 
Qualitative analysis revealed that performing ischemic preconditioning before sprint activity 205 
led to a likely increase in maximum peak power output (2.5 ± 1.9%, 93%, small (%∆, % 206 
likelihood, effect size)). Raw peak and mean power output data for each sprint are presented 207 
in Figures 1 and 2, respectively. Ischemic preconditioning, relative to placebo, resulted in 208 
substantial increases in peak power output for sprints 1 (2.4 ± 2.2%, 89% likely, small), 2 (2.6 209 
± 2.7%, 87% likely, small) and 3 (3.7 ± 2.4%, 97% very likely, small) only, with effects 210 
unclear for the remaining sprints. Mean power output followed a similar pattern with 211 
substantial increases in sprints 1 (2.8 ± 2.5%, 91% likely, small), 2 (2.6 ± 2.5%, 88% likely, 212 
 The is a non-final version of an article published in final form in Medicine and Science in 
Sport and Exercise (2015) Aug;47(8):1652-8. doi: 10.1249/MSS.0000000000000576 
 
small) and 3 (3.4 ± 2.1%, 98% very likely, small) for the ischemic preconditioning trial, 213 
relative to placebo, and the effects on the remaining sprints were deemed unclear. During the 214 
repeated sprint cycling protocol, fatigue was evident in both trials as represented by Sdec 215 
values of 13.2 ± 5.6% and 14.7 ± 5.9% for placebo and ischemic preconditioning, 216 
respectively. Qualitative analysis revealed a possibly greater fatigue rate when repeated sprint 217 
cycling was performed following ischemic preconditioning (13.5 ± 16%, 64% possible, 218 
small). 219 
Blood lactate was not different at rest prior to the placebo and ischemic preconditioning trials 220 
(mean ± SD; 1.1 ± 0.2 and 1.0 ± 0.3 mmol.L
-1
, respectively; unclear, trivial). Blood lactate 221 
was possibly higher when measured at sprints, 4, 8 and 12 in the ischemic preconditioning 222 
(Table 1). Relative to placebo, the effects of ischemic preconditioning on perceived exertion 223 
at sprints 4, 8 and 12 were -0.1 ± 0.6, 0.2 ± 0.7 and 0.1 ± 0.8 (arbitrary units), respectively, 224 
with qualitative analysis interpretation deeming differences and effect sizes as unclear or 225 
trivial. Data for TSI are presented in Table 1. Briefly, effects for TSI at rest, between trials 226 
were unclear. During the occlusion / preconditioning stimulus there was an almost certain 227 
decrease in TSI during the ischemic preconditioning trial, relative to placebo. During exercise 228 
there was a likely higher increase in TSI in the ischemic preconditioning trial when compared 229 
with placebo (Table 1). At rest and during exercise, differences in oxygen uptake between 230 
trials were unclear (Table 1). The rate of change in MDF of EMG was possibly higher in the 231 
ischemic preconditioning trial, relative to the placebo trial (Table 1).  232 
DISCUSSION 233 
The main aim of this study was to investigate the effect of ischemic preconditioning on 234 
repeated sprint cycling performance. Relative to placebo, the results showed that ischemic 235 
preconditioning was associated with a 2 – 4% increase in both mean and peak power output 236 
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in the early phase of the protocol. The improvement in power output is similar to other 237 
ergogenic aids used during this type of exercise (15, 16) and to performance improvements 238 
observed following ischemic preconditioning using different exercise modes (12, 24). 239 
The present investigation is the first to demonstrate an improved power output following 240 
ischemic preconditioning during a repeated sprint protocol. Despite rejecting our hypothesis, 241 
we did observe substantial increases in both peak and mean power output for the first three 242 
sprints. Previous research has demonstrated an improved muscle force production following 243 
ischemia and reperfusion in animal (21, 26) and human models (27). Due to the original aim 244 
and thus design of the study it was not possible to determine the contribution of increased 245 
motor unit recruitment to improved performance, although it does remain a possibility. EMG 246 
amplitude has previously been demonstrated to increase in skeletal muscle of animals 247 
following ischemic preconditioning (36), suggesting increased motor unit recruitment. In the 248 
only relevant human study, muscle fibre conduction velocity, which measures the speed of 249 
action potential or excitatory impulse, is increased during isometric exercise; yet ischemic 250 
preconditioning did not play a role (37).  251 
It is recognized that high energy compounds are important for energy production during 252 
repeated sprint activity, with total anaerobic contributions of ATP production during a single 253 
6 s sprint being 6%, 50% and 44% from ATP, PCr and anaerobic glycolysis, respectively 254 
(18).  Whilst speculative, it is possible that the increased power production in the first three 255 
sprints in the ischemic preconditioning trial may have been a result of increased ATP 256 
production from anaerobic sources. Following ischemic reperfusion injury ATP content is 257 
maintained in rabbit and mice heart muscle as a result of ischemic preconditioning via 258 
increased concentration of PCr and PCr / ATP ratio (29) or increased anaerobic glycolysis 259 
(23). To date little evidence is available on concentrations in skeletal muscle, however 260 
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increased PCr production has been observed using 
31
P MRS in recovery from an ischemic 261 
event (1). Therefore it is possible that improved power output may be a result of increased 262 
anaerobic energy contribution early in the sprint protocol. Within the current study a possible 263 
increased blood lactate concentration was observed following the fourth sprint in the 264 
ischemic preconditioning trial, giving further weight to this suggestion although it was not a 265 
substantial effect.   266 
Originally, it was hypothesised that ischemic preconditioning would improve aerobic 267 
metabolism and thus improve the ability to recover between sprints. Markers of aerobic 268 
fitness such as V̇O2max and V̇O2 kinetic parameters are related to the ability to offset fatigue 269 
during a repeated sprint effort (14, 30), whilst an increased aerobic energy production 270 
contributes towards power production in the latter stages of repeated intense exercise (6, 18, 271 
30). Previous research employing one bout of circulatory occlusion prior to the start of an 272 
exercise bout has demonstrated accelerated pulmonary V̇O2 kinetics (34). Moreover ischemic 273 
preconditioning has been shown to increase V̇O2max (13), suggesting that the method may be 274 
used to help maintain power output during repeated sprint exercise, via improved PCr 275 
resynthesis (9, 18, 34). However, data from the present study does not support this theory as 276 
evidenced by the similarity between trials for V̇O2 during the repeated sprint protocol.    277 
Alongside an increased aerobic metabolism, ischemic preconditioning has been associated 278 
with improved muscle oxygenation during and in recovery from exercise (38). As expected, 279 
TSI was almost certainly decreased by 20% during the preconditioning stimulus, relative to 280 
placebo, which is similar to a previous investigation (25). However, during exercise, TSI was 281 
likely maintained at a higher level in the ischemic preconditioning trial. Since TSI reflects the 282 
dynamic balance between O2 supply and O2 consumption, the greater TSI observed during 283 
the ischemic preconditioning trial is indicative of an improved O2 delivery at the muscle level 284 
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(11). This may explain the maintenance of power output in the latter sprints in the ischemic 285 
preconditioning condition, despite the higher power outputs early in the trial and place the 286 
emphasis on greater O2 delivery. It should be noted, however, that muscle oxygenation is not 287 
a limiting factor during repeated sprint activity (39). Instead, it may be that ischemic 288 
preconditioning increases blood flow to skeletal muscle (40), thereby improving power 289 
maintenance by increasing microvascular pressure, and/or by increasing metabolite washout 290 
(27). However, this mechanism is questionable given that blood flow returns to resting levels 291 
within 20 minutes of cuff release (7). 292 
Previous research investigating ischemic preconditioning in exercise involving sprint activity 293 
has provided conflicting evidence. Elite swimming performance (100 m) is enhanced 294 
following ischemic preconditioning (24); however, the time taken to complete the event was 295 
~66 s, thus not typical of a sprint experienced in team sports. Moreover, no effect of ischemic 296 
preconditioning has been demonstrated during ‘all-out’ sprint exercise at 130% V̇O2max or 30 297 
m land based sprint running (12, 19). Whilst these results differ from the ones in the current 298 
study they may be explained by the timing of the preconditioning strategy. Previous studies 299 
have performed a warm up immediately post the preconditioning stimulus and moved straight 300 
into the exercise regime (19). In the current study, the warm up was started 30 minutes post 301 
the ischemic preconditioning stimulus to make the research more applicable to an athletic 302 
setting. Current research investigating performance immediately after the ischemic 303 
preconditioning stimulus may be confined to a laboratory setting due to the impracticality of 304 
performing a similar action in an athletic event. It may be that the extra recovery time 305 
following the ischemic preconditioning stimulus is more beneficial for sprint related activity 306 
as demonstrated by the increased power output in the first three sprints. Due to the evidence 307 
in a controlled laboratory environment and protocol in the current study, future research 308 
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should focus on the mechanisms for improved performance and application of ischemic 309 
preconditioning in events which mimic actual performance events.  310 
In conclusion, ischemic preconditioning of skeletal muscle likely increases both mean and 311 
peak power output in the first three sprints by 2-4% during the early stages of repeated sprint 312 
cycling. This was in contrast to our hypothesis that ischemic preconditioning would improve 313 
Sdec through aerobic metabolism. Moreover Sdec was not substantially different between trials, 314 
possibly due to maintenance of TSI in the ischemic preconditioning condition. Further 315 
research is required to establish the mechanisms for increased power output during repeated 316 
sprint cycling following ischemic preconditioning. Overall the results of this study suggest 317 
that ischemic preconditioning is a potential aid for improving sprint based performance.  318 
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 471 
Figure Legends 472 
Figure 1. Peak power output data during twelve maximal 6 s sprints following ischemic 473 
preconditioning (solid bars) or placebo (open bars). Data are mean ± SD. * indicates 474 
substantially different from placebo (> 75% likelihood). 475 
Figure 2. Mean power output data during twelve maximal 6 s sprints following ischemic 476 
preconditioning (sold bars) or placebo (open bars). Data are mean ± SD. * indicates 477 
substantially different from placebo (> 75% likelihood). 478 
Table Legends 479 
Table 1. Statistical summary of the differences between ischemic preconditioning and 480 
placebo for oxygen uptake, tissue saturation index, EMG, and blood lactate. 481 
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Table 1.  
90% CI = 90% confidence interval 
a Mean change refers to ischemic preconditioning minus placebo trial.  
b Inference about the magnitude of the effect 
Bold inferences (% likelihood) indicate conditions with substantial change (> 75% 
likelihood). 
 Placebo Ischemic 
preconditioning 
Mean 
Change
a
; ± 
90% CI 
(%) 
Qualitative 
Inference
b
 
(% 
Likelihood) 
 
Effect Size 
(Qualitative 
Descriptor) 
V̇O2 Rest 
(L.min
-1
) 
0.4 ± 0.1 0.4 ± 0.1 1.9 ± 15.6 Unclear 0.08 (trivial) 
V̇O2 
Exercise 
(L.min
-1
) 
2.6 ± 0.3 2.7 ± 0.4 4.3 ± 7.3 Unclear 0.29 (small) 
TSI Rest 
(%) 
71.8 ± 5.1 73.0 ± 4.0 1.7 ± 3.6 Unclear 0.24 (small) 
TSI 
Occlusion 
(%) 
72.3 ± 5.5 58.0 ± 4.2 -19.7 ± 3.6 Almost 
Certainly 
decreased 
(100%) 
2.77 (Large) 
TSI Exercise 
(%) 
57.7 ± 5.0 60.9 ± 6.0 5.4 ± 4.8 Likely 
Increased 
(93%) 
0.56 
(Moderate) 
Rate of 
change in 
EMG MDF 
(Hz/sprint) 
-0.04± 
0.43 
-0.28 ± 0.42 48.9 ± 69.7 Possibly 
Higher 
(73%) 
0.37 (small) 
Sprint 4 
Blood 
Lactate 
(mmol.L
-1
) 
6.9 ± 2.1 7.5 ± 2.3 7.1 ± 11.4 Possibly 
Higher 
(50%) 
0.19 (trivial) 
Sprint 8 
Blood 
Lactate 
(mmol.L
-1
) 
9.6 ± 2.8 10.2 ± 2.3 4.3 ± 6.4 Possibly 
Higher 
(25%) 
0.12 (trivial) 
Sprint 12 
Blood 
Lactate 
(mmol.L
-1
) 
11.1 ± 3.5 11.8 ± 2.7 5.5 ± 6.4 Possibly 
Higher 
(26%) 
0.13 (trivial) 
